Physician

Eric Scott Schaefer, M.D.

According to 2025 Medicare claims, Eric Schaefer, M.D. (NPI: 1558325118) practices hematology/oncology in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Benton, AR. This provider's primary affiliated billing organization is HIGHLANDS ONCOLOGY GROUP PA (NPI: 1346211323; TIN: 710788742) and primary practice location at 72758-8602.

Schaefer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,492 traditional Medicare patients, billed 313,522 HCPCS/CPT codes, and received $5,080,054 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 3,042 prescription claims across 533 beneficiaries totaling $4,505,614 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 145 claims. Open Payments data shows 269 records totaling $765,734. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,371,491 to $4,505,614. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $17,772 and ending at $7,192.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,207	261,027	$3,324,633
2016	1,239	339,862	$4,011,639
2017	1,421	384,957	$5,101,763
2018	1,489	413,046	$5,106,451
2019	1,557	519,625	$6,524,197
2020	1,474	389,859	$6,199,486
2021	1,689	401,788	$5,954,995
2022	1,368	328,211	$4,985,312
2023	1,385	361,264	$5,604,066
2024	1,492	313,522	$5,080,054

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	396	2,957	$2,371,491
2016	411	3,004	$2,027,225
2017	454	3,091	$1,544,287
2018	459	3,130	$2,806,867
2019	567	2,859	$2,771,223
2020	593	2,849	$2,108,920
2021	488	2,833	$2,988,509
2022	422	2,809	$3,315,721
2023	559	2,681	$2,802,262
2024	533	3,042	$4,505,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	274	$47,491
2016	11	161	$29,502
2017	16	167	$5,564
2018	N/R	118	$9,054
2019	14	91	$5,064
2020	11	228	$58,635
2021	11	178	$39,253
2022	11	82	$4,456
2023	N/R	181	$9,594
2024	11	145	$10,539

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	794	2,373	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	829	2,635	$8
83735	Magnesium level	773	2,357	$7
83615	Lactate dehydrogenase (enzyme) level	772	2,318	$6
82248	Bilirubin level, direct	771	2,316	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	65	1,948	$1,002,651
Ojjaara	Momelotinib Dihydrochloride	20	600	$567,963
Tagrisso	Osimertinib Mesylate	26	900	$492,288
Revlimid	Lenalidomide	28	784	$481,587
Xtandi	Enzalutamide	31	930	$444,705

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	54	$4,185
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	15	$3,814
J8700	Temozolomide, oral, 5 mg	N	N/R	11	$1,007
E1392	Portable oxygen concentrator, rental	Y	N/R	23	$831
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	29	$476

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	125	$59,360	Cornerstone Specialty Network LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	142	$706,374	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$25,650	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Eric Scott Schaefer, M.D.?

Tedicare shows public-source Medicare data for Eric Scott Schaefer, M.D. (NPI 1558325118), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric Scott Schaefer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eric Scott Schaefer, M.D.?

Eric Scott Schaefer, M.D. is linked to HIGHLANDS ONCOLOGY GROUP PA (billing NPI 1346211323) in the available physician profile data.

Does Eric Scott Schaefer, M.D. have Open Payments data?

Eric Scott Schaefer, M.D. has 269 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.